Symbols / AFIB
AFIB Chart
About
Acutus Medical, Inc. designs, manufactures, and markets various tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. Its product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Medical Devices | Market Cap | 5.98K |
| Enterprise Value | 21.75M | Income | -4.54M | Sales | 20.16M |
| Book/sh | -0.39 | Cash/sh | 0.47 | Dividend Yield | — |
| Payout | 0.00% | Employees | 85 | IPO | — |
| P/E | — | Forward P/E | -0.00 | PEG | — |
| P/S | 0.00 | P/B | -0.00 | P/C | — |
| EV/EBITDA | -2.38 | EV/Sales | 1.08 | Quick Ratio | 1.61 |
| Current Ratio | 2.06 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -0.15 | EPS next Y | -2.19 | EPS Growth | — |
| Revenue Growth | 203.70% | Earnings | 2023-11-08 16:00 | ROA | -14.26% |
| ROE | — | ROIC | — | Gross Margin | 5.03% |
| Oper. Margin | -21.75% | Profit Margin | -47.36% | Shs Outstand | 29.91M |
| Shs Float | 24.78M | Short Float | 1.91% | Short Ratio | 0.68 |
| Short Interest | — | 52W High | 0.06 | 52W Low | 0.00 |
| Beta | -1.25 | Avg Volume | 7.33K | Volume | 10.00K |
| Target Price | — | Recom | None | Prev Close | $0.00 |
| Price | $0.00 | Change | 0.00% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.00
Latest analyst target
3. DCF / Fair value
$-4.08
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.00
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2022-08-16 | main | Goldman Sachs | — → Neutral | $2 |
| 2022-06-24 | main | BTIG | — → Buy | $2 |
| 2022-04-27 | up | BTIG | Neutral → Buy | $2 |
| 2022-04-14 | main | Goldman Sachs | — → Neutral | $1 |
| 2022-01-20 | down | BTIG | Buy → Neutral | — |
| 2022-01-14 | down | Canaccord Genuity | Buy → Hold | $3 |
| 2021-11-12 | down | JP Morgan | Neutral → Underweight | — |
| 2021-11-12 | main | Canaccord Genuity | — → Buy | $10 |
| 2021-10-22 | init | Goldman Sachs | — → Neutral | $10 |
| 2021-07-15 | up | Canaccord Genuity | Hold → Buy | $18 |
| 2021-03-19 | main | Canaccord Genuity | — → Hold | $16 |
| 2021-03-19 | down | William Blair | Outperform → Market Perform | — |
| 2021-03-19 | down | JP Morgan | Overweight → Neutral | $19 |
| 2021-01-14 | down | B of A Securities | Buy → Neutral | — |
| 2020-08-31 | init | William Blair | — → Outperform | — |
| 2020-08-31 | init | Canaccord Genuity | — → Hold | $30 |
| 2020-08-31 | init | B of A Securities | — → Buy | $38 |
| 2020-08-31 | init | JP Morgan | — → Overweight | $39 |
- Heart treatment innovator AtriCure joins Citizens Life Sciences forum - Stock Titan ue, 24 Feb 2026 13
- Can a Coffee a Day Keep AFib Away? - AJMC hu, 13 Nov 2025 08
- EGRMC's Dr. Richard Petrella's study highlights the urgent need for better AFib prevention and treatment - Grice Connect Sat, 16 Aug 2025 07
- Abbott stock price: Insider buy and fresh AFib data put ABT back on watch for Monday - TechStock² Sun, 08 Feb 2026 08
- Milestone stock soars after FDA approves first self-administered PSVT spray - Investing.com Mon, 15 Dec 2025 08
- AtriCure launches first-of-its-kind clinical trial to prevent post-operative atrial fibrillation - Medical Economics ue, 28 Oct 2025 07
- Smartwatches detect AFib with high diagnostic accuracy - TechTarget Fri, 21 Nov 2025 08
- Oversold Conditions For Strategy (MSTR) - Nasdaq Mon, 15 Dec 2025 08
- Catheter trials show Abbott devices cut AFib episodes for most patients - Stock Titan Fri, 06 Feb 2026 08
- Abbott stock rises on AFib device data buzz as traders weigh FDA overhang - Bez Kabli ue, 10 Feb 2026 08
- Johnson & Johnson stock price: What to watch after talc-case law firm ouster and new AFib data - TechStock² Sat, 07 Feb 2026 08
- AFIB Stock Price and Chart — OTC:AFIB - TradingView Wed, 05 Aug 2020 07
- Why Is Acutus Medical (AFIB) Stock Down 41% Today? - InvestorPlace Mon, 06 May 2024 07
- Pulse Biosciences Gets FDA IDE Nod for Atrial Fibrillation Study - Nasdaq hu, 11 Sep 2025 07
- New Medtronic AFib catheter gets EU CE Mark, starts pivotal U.S. trial - Stock Titan Fri, 23 Jan 2026 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 2.50M | 30.40K | 0.00 |
| TaxRateForCalcs | 0.00 | 0.21 | 0.00 | 0.00 |
| NormalizedEBITDA | -7.33M | -17.22M | -23.27M | -108.86M |
| TotalUnusualItems | 9.58M | 11.89M | 58.47M | 3.75M |
| TotalUnusualItemsExcludingGoodwill | 9.58M | 11.89M | 58.47M | 3.75M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -4.54M | -11.92M | 28.83M | -117.68M |
| ReconciledDepreciation | 1.03M | 874.00K | 1.21M | 6.89M |
| ReconciledCostOfRevenue | 19.14M | 10.30M | 4.94M | 32.92M |
| EBITDA | 2.25M | -5.33M | 35.20M | -105.12M |
| EBIT | 1.22M | -6.20M | 34.00M | -112.01M |
| NetInterestIncome | -5.00M | -3.07M | -4.28M | -5.56M |
| InterestExpense | 5.76M | 5.66M | 5.15M | 5.68M |
| InterestIncome | 763.00K | 2.59M | 868.00K | 116.00K |
| NormalizedIncome | -14.12M | -21.32M | -29.61M | -121.43M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -9.55M | -81.66M | -39.62M | -117.68M |
| TotalExpenses | 29.58M | 27.85M | 28.37M | 133.13M |
| TotalOperatingIncomeAsReported | -57.00K | -11.73M | 41.04M | -112.12M |
| DilutedAverageShares | 29.10M | 28.32M | 28.65M | |
| BasicAverageShares | 29.10M | 28.32M | 28.65M | |
| DilutedEPS | -2.81 | -1.40 | -4.11 | |
| BasicEPS | -2.81 | -1.40 | -4.11 | |
| DilutedNIAvailtoComStockholders | -9.55M | -81.66M | -39.62M | -117.68M |
| NetIncomeCommonStockholders | -9.55M | -81.66M | -39.62M | -117.68M |
| NetIncome | -9.55M | -81.66M | -39.62M | -117.68M |
| NetIncomeIncludingNoncontrollingInterests | -9.55M | -81.66M | -39.62M | -117.68M |
| NetIncomeDiscontinuousOperations | -5.01M | -69.74M | -68.45M | |
| NetIncomeContinuousOperations | -4.54M | -11.92M | 28.83M | -117.68M |
| TaxProvision | 0.00 | 63.00K | 15.00K | 0.00 |
| PretaxIncome | -4.54M | -11.86M | 28.85M | -117.68M |
| OtherIncomeExpense | 9.88M | 11.89M | 58.47M | 3.75M |
| OtherNonOperatingIncomeExpenses | 301.00K | |||
| SpecialIncomeCharges | 9.37M | 8.96M | 58.44M | 3.75M |
| GainOnSaleOfBusiness | 10.81M | 9.08M | 79.47M | 0.00 |
| OtherSpecialCharges | 7.95M | |||
| ImpairmentOfCapitalAssets | 0.00 | 12.03M | 0.00 | |
| RestructuringAndMergernAcquisition | 1.45M | 123.00K | 1.05M | -3.75M |
| GainOnSaleOfSecurity | 215.00K | 2.94M | 33.00K | |
| NetNonOperatingInterestIncomeExpense | -5.00M | -3.07M | -4.28M | -5.56M |
| InterestExpenseNonOperating | 5.76M | 5.66M | 5.15M | 5.68M |
| InterestIncomeNonOperating | 763.00K | 2.59M | 868.00K | 116.00K |
| OperatingIncome | -9.42M | -20.68M | -25.34M | -115.87M |
| OperatingExpense | 10.44M | 17.55M | 23.43M | 100.21M |
| ResearchAndDevelopment | 0.00 | 3.48M | 3.12M | 36.68M |
| SellingGeneralAndAdministration | 10.44M | 14.07M | 20.32M | 63.52M |
| GrossProfit | 1.01M | -3.14M | -1.91M | -15.66M |
| CostOfRevenue | 19.14M | 10.30M | 4.94M | 32.92M |
| TotalRevenue | 20.16M | 7.16M | 3.03M | 17.26M |
| OperatingRevenue | 20.16M | 7.16M | 3.03M | 17.26M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 29.91M | 29.31M | 28.55M | 27.96M |
| ShareIssued | 29.91M | 29.31M | 28.55M | 27.96M |
| NetDebt | 18.55M | 15.35M | 8.85M | 16.34M |
| TotalDebt | 35.76M | 38.48M | 38.86M | 45.40M |
| TangibleBookValue | -11.59M | -879.00K | 75.02M | 88.69M |
| InvestedCapital | 20.98M | 33.64M | 109.45M | 146.14M |
| WorkingCapital | 13.14M | 27.31M | 98.00M | 107.78M |
| NetTangibleAssets | -11.59M | -879.00K | 75.02M | 88.69M |
| CapitalLeaseObligations | 3.19M | 3.96M | 4.42M | 4.99M |
| CommonStockEquity | -11.59M | -879.00K | 75.02M | 105.73M |
| TotalCapitalization | 13.97M | 31.77M | 109.45M | 146.14M |
| TotalEquityGrossMinorityInterest | -11.59M | -879.00K | 75.02M | 105.73M |
| StockholdersEquity | -11.59M | -879.00K | 75.02M | 105.73M |
| GainsLossesNotAffectingRetainedEarnings | -768.00K | -866.00K | -869.00K | -217.00K |
| OtherEquityAdjustments | -768.00K | -866.00K | -869.00K | -217.00K |
| RetainedEarnings | -609.52M | -599.98M | -518.31M | -478.70M |
| AdditionalPaidInCapital | 598.67M | 599.93M | 594.17M | 584.61M |
| CapitalStock | 30.00K | 29.00K | 29.00K | 28.00K |
| CommonStock | 30.00K | 29.00K | 29.00K | 28.00K |
| PreferredStock | 0.00 | 0.00 | 0.00 | 0.00 |
| TotalLiabilitiesNetMinorityInterest | 40.24M | 54.84M | 58.42M | 64.07M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 27.80M | 35.90M | 38.55M | 45.56M |
| OtherNonCurrentLiabilities | 12.00K | 550.00K | ||
| LongTermDebtAndCapitalLeaseObligation | 27.80M | 35.90M | 38.54M | 45.01M |
| LongTermCapitalLeaseObligation | 2.24M | 3.24M | 4.10M | 4.59M |
| LongTermDebt | 25.56M | 32.65M | 34.43M | 40.41M |
| CurrentLiabilities | 12.44M | 18.94M | 19.87M | 18.51M |
| OtherCurrentLiabilities | 194.00K | 10.71M | 13.77M | 1.50M |
| CurrentDeferredLiabilities | 326.00K | 401.00K | ||
| CurrentDeferredRevenue | 326.00K | 401.00K | ||
| CurrentDebtAndCapitalLeaseObligation | 7.96M | 2.58M | 319.00K | 395.00K |
| CurrentCapitalLeaseObligation | 957.00K | 718.00K | 319.00K | 395.00K |
| CurrentDebt | 7.00M | 1.86M | ||
| OtherCurrentBorrowings | 7.00M | 1.86M | ||
| PensionandOtherPostRetirementBenefitPlansCurrent | 983.00K | 2.23M | 2.43M | 7.09M |
| PayablesAndAccruedExpenses | 3.30M | 3.42M | 3.35M | 9.13M |
| CurrentAccruedExpenses | 2.02M | 662.00K | 696.00K | 1.54M |
| Payables | 1.28M | 2.76M | 2.65M | 7.59M |
| TotalTaxPayable | 0.00 | 181.00K | 71.00K | |
| AccountsPayable | 1.28M | 2.76M | 2.47M | 7.52M |
| TotalAssets | 28.65M | 53.96M | 133.44M | 169.79M |
| TotalNonCurrentAssets | 3.07M | 7.71M | 15.57M | 43.50M |
| OtherNonCurrentAssets | 94.00K | 3.69M | 10.03M | 1.15M |
| InvestmentsAndAdvances | 0.00 | 7.12M | ||
| InvestmentinFinancialAssets | 0.00 | 7.12M | ||
| AvailableForSaleSecurities | 7.12M | |||
| GoodwillAndOtherIntangibleAssets | 1.58M | 17.04M | ||
| OtherIntangibleAssets | 1.58M | 5.01M | ||
| Goodwill | 0.00 | 12.03M | ||
| NetPPE | 2.98M | 4.01M | 5.54M | 18.19M |
| AccumulatedDepreciation | -3.72M | -3.62M | -3.36M | -11.90M |
| GrossPPE | 6.69M | 7.64M | 8.90M | 30.09M |
| Leases | 949.00K | 979.00K | 580.00K | 582.00K |
| ConstructionInProgress | 41.00K | 7.00K | 980.00K | 958.00K |
| OtherProperties | 2.46M | 3.19M | 3.87M | 21.28M |
| MachineryFurnitureEquipment | 3.24M | 3.46M | 3.46M | 7.27M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 25.58M | 46.25M | 117.87M | 126.29M |
| OtherCurrentAssets | 641.00K | 678.00K | 1.25M | 5.33M |
| AssetsHeldForSaleCurrent | 1.25M | 510.00K | 15.99M | |
| RestrictedCash | 0.00 | 7.03M | 5.76M | 150.00K |
| PrepaidAssets | 5.33M | |||
| Inventory | 1.79M | 4.28M | 1.79M | 16.41M |
| FinishedGoods | 21.00K | 531.00K | 719.00K | 7.86M |
| WorkInProcess | 583.00K | 319.00K | 197.00K | 1.77M |
| RawMaterials | 1.19M | 3.43M | 878.00K | 6.78M |
| Receivables | 7.88M | 11.35M | 22.62M | 3.63M |
| OtherReceivables | 4.70M | |||
| AccountsReceivable | 7.88M | 11.35M | 17.92M | 3.63M |
| CashCashEquivalentsAndShortTermInvestments | 14.02M | 22.40M | 70.45M | 100.77M |
| OtherShortTermInvestments | 0.00 | 3.23M | 44.86M | 76.70M |
| CashAndCashEquivalents | 14.02M | 19.17M | 25.58M | 24.07M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -31.77M | -63.34M | -89.14M | -109.66M |
| RepurchaseOfCapitalStock | 0.00 | -111.00K | 0.00 | |
| RepaymentOfDebt | -2.62M | 0.00 | -44.55M | 0.00 |
| IssuanceOfDebt | 0.00 | 34.83M | 0.00 | |
| IssuanceOfCapitalStock | 0.00 | 82.66M | ||
| CapitalExpenditure | -112.00K | -219.00K | -228.00K | -9.97M |
| InterestPaidSupplementalData | 4.54M | 5.01M | 4.23M | 4.26M |
| EndCashPosition | 14.02M | 26.20M | 31.35M | 24.22M |
| BeginningCashPosition | 26.20M | 31.35M | 24.22M | 25.38M |
| EffectOfExchangeRateChanges | 221.00K | 2.08M | 2.91M | -116.00K |
| ChangesInCash | -12.40M | -7.23M | 4.22M | -1.05M |
| FinancingCashFlow | -2.89M | -2.66M | -11.62M | 79.57M |
| CashFromDiscontinuedFinancingActivities | -41.00K | -280.00K | 0.00 | |
| CashFlowFromContinuingFinancingActivities | -2.85M | -2.38M | -11.62M | 79.57M |
| NetOtherFinancingCharges | -225.00K | -2.41M | -2.06M | -4.24M |
| ProceedsFromStockOptionExercised | 0.00 | 29.00K | 281.00K | 1.15M |
| NetCommonStockIssuance | 0.00 | -111.00K | 82.66M | |
| CommonStockPayments | 0.00 | -111.00K | 0.00 | |
| CommonStockIssuance | 0.00 | 82.66M | ||
| NetIssuancePaymentsOfDebt | -2.62M | 0.00 | -9.72M | 0.00 |
| NetLongTermDebtIssuance | -2.62M | 0.00 | -9.72M | 0.00 |
| LongTermDebtPayments | -2.62M | 0.00 | -44.55M | 0.00 |
| LongTermDebtIssuance | 0.00 | 34.83M | 0.00 | |
| InvestingCashFlow | 22.15M | 58.55M | 104.75M | 19.07M |
| CashFromDiscontinuedInvestingActivities | 339.00K | -1.21M | -3.75M | |
| CashFlowFromContinuingInvestingActivities | 21.81M | 59.77M | 108.50M | 19.07M |
| NetInvestmentPurchaseAndSale | 3.25M | 42.98M | 38.73M | 29.04M |
| SaleOfInvestment | 3.25M | 82.75M | 93.24M | 116.30M |
| PurchaseOfInvestment | 0.00 | -39.77M | -54.51M | -87.26M |
| NetBusinessPurchaseAndSale | 18.67M | 17.00M | 70.00M | 0.00 |
| SaleOfBusiness | 18.67M | 17.00M | 70.00M | 0.00 |
| NetPPEPurchaseAndSale | -112.00K | -219.00K | -228.00K | -9.97M |
| PurchaseOfPPE | -112.00K | -219.00K | -228.00K | -9.97M |
| OperatingCashFlow | -31.66M | -63.12M | -88.92M | -99.68M |
| CashFromDiscontinuedOperatingActivities | -14.47M | -43.27M | -58.07M | |
| CashFlowFromContinuingOperatingActivities | -17.18M | -19.85M | -30.85M | -99.68M |
| ChangeInWorkingCapital | -4.01M | 916.00K | -2.61M | -3.79M |
| ChangeInOtherCurrentLiabilities | -766.00K | -473.00K | -1.06M | -558.00K |
| ChangeInOtherCurrentAssets | 0.00 | 0.00 | 304.00K | |
| ChangeInPayablesAndAccruedExpense | -1.73M | -412.00K | 1.23M | 678.00K |
| ChangeInAccruedExpense | -246.00K | -700.00K | 1.43M | 1.55M |
| ChangeInPayable | -1.49M | 288.00K | -204.00K | -871.00K |
| ChangeInAccountPayable | -1.49M | 288.00K | -204.00K | -871.00K |
| ChangeInPrepaidAssets | 48.00K | 656.00K | 2.45M | 1.13M |
| ChangeInInventory | 2.49M | -2.48M | -65.00K | -3.87M |
| ChangeInReceivables | -4.05M | 3.63M | -5.17M | -1.47M |
| ChangesInAccountReceivables | -4.05M | -1.07M | -464.00K | -1.47M |
| OtherNonCashItems | 931.00K | 694.00K | 66.33M | -160.00K |
| StockBasedCompensation | 459.00K | 3.03M | 3.40M | 13.75M |
| AssetImpairmentCharge | 0.00 | 12.03M | 0.00 | |
| AmortizationOfSecurities | -28.00K | -1.43M | -24.00K | 1.28M |
| DepreciationAmortizationDepletion | 1.03M | 874.00K | 1.21M | 6.89M |
| DepreciationAndAmortization | 1.03M | 874.00K | 1.21M | 6.89M |
| AmortizationCashFlow | 0.00 | 220.00K | 640.00K | |
| AmortizationOfIntangibles | 0.00 | 220.00K | 640.00K | |
| Depreciation | 1.03M | 874.00K | 988.00K | 6.25M |
| OperatingGainsLosses | -11.03M | -12.02M | -71.55M | 28.00K |
| GainLossOnInvestmentSecurities | -215.00K | -2.94M | -33.00K | |
| GainLossOnSaleOfPPE | 0.00 | 0.00 | 28.00K | |
| GainLossOnSaleOfBusiness | -10.81M | -9.08M | -79.47M | 0.00 |
| NetIncomeFromContinuingOperations | -4.54M | -11.92M | -39.62M | -117.68M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for AFIB
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|